T he nucleus tractus solitarius (NTS) is the first site of baroreceptor afferent integration within the central nervous system. 1, 2 The synaptic transmission of baroreceptor afferents within the NTS is constantly modulated by both excitatory and inhibitory inputs mediated by many neurotransmitters, including the inhibitory neurotransmitter ␥-aminobutyric acid (GABA). Microinjection of baclofen, a selective GABA B-subtype (GABA B ) receptor agonist, into the NTS results in an increase in arterial pressure, heart rate, and renal sympathetic nerve discharge, [3] [4] [5] which are expected, because baclofen inhibits NTS neurons that integrate baroreceptor afferent inputs. 6 -8 This baclofen-induced pressor response is enhanced in several animal models of chronic hypertension, including the spontaneously hypertensive rat, 9,10 deoxycorticosterone salt-hypertensive rats, 11 and 1-kidney, renal wrap models of hypertension. 6 -8,12 Baclofen can presynaptically inhibit glutamate release from afferent terminals and postsynaptically induce outward current to reduce neuronal excitability in the NTS. 13 However, it is not known to what extent postsynaptic GABA B receptor-mediated inhibition contributes to the enhanced baclofen-induced pressor response in chronic hypertension.
Previous studies from this laboratory have demonstrated that renal-wrap hypertension is associated with increased GABA B receptor-mediated inhibition of baroreceptor-evoked discharge in NTS neurons 8 and increased expression of GABA B receptor mRNA in the NTS. 7 To clarify GABA B receptor-mediated cellular mechanisms in the neuronal adaptations to chronic hypertension, the present study investigated the postsynaptic effect of baclofen on NTS neurons receiving monosynaptic afferent inputs from baroreceptors and the influence of chronic hypertension on the postsynaptic response to baclofen. We addressed these questions using an in vitro patch-clamp method to directly investigate the postsynaptic effect of baclofen on second-order baroreceptor neurons in the NTS. The results demonstrated that, after chronic hypertension, second-order neurons showed enhanced postsynaptic responses to baclofen. This enhanced postsynaptic baclofen effect could contribute to the enhanced baclofen-induced pressor response observed in chronic hypertension and altered baroreflex function in hypertension. 14 
Methods
All of the experimental protocols in this work were reviewed and approved by the Institutional Animal Care and Use Committee at the University of Texas Health Science Center at San Antonio.
Surgical Preparation for Labeling Aortic Nerve
Male Sprague-Dawley rats (100 to 125 g, Charles River, Wilmington, MA) were anesthetized with a combination of ketamine (75 mg/kg IP; Ft Dodge) and medetomidine (0.5 mg/kg IP; Pfizer). Under aseptic conditions, crystals of anterograde fluorescent dye 1,1Ј-dilinoleyl-3,3,3Ј,3Ј-tetra-methylindocarbocyanine, 4-chlorobenzenesulphonate ([DiA] D-3883, Molecular Probes) were gently applied unilaterally to the aortic nerve to visualize baroreceptor synaptic terminals and neurons receiving these synaptic contacts. [15] [16] [17] The area was then embedded with silicone adhesive (Kwik-Sil, WPI). Anesthesia was terminated by atipamezole (1 mg/kg IP, Pfizer) at the conclusion of the surgical procedures. Postoperative analgesics (Nubaine, IM) were available as needed. The rats were allowed to recover for Ն1 week before performing renal wrap/sham surgery.
Chronic Hypertensive Model
Rats were anesthetized using the ketamine/medetomidine described above. Hypertension was induced using a figure-8 renal wrap of 1 kidney, and contralateral nephrectomy were performed. 18 Control animals were sham-operated rats that only received a unilateral nephrectomy but no wrap of the contralateral kidney. Anesthesia was terminated by atipamezole, and postoperative analgesics (Nubaine, IM) were available as needed.
Four weeks after renal wrap or sham surgery, an arterial catheter was placed in the femoral artery while the animal was under ketamine/medetomidine anesthesia as described above. After a 2-day recovery period, the blood pressure of the conscious animal was measured by connecting the arterial catheter to a pressure transducer (Kobe) and displayed by means of a Cambridge Electronics Design A/D converter (CED). Blood pressure was measured for 3 hours, and measurements made during the last hour were used as an index of mean arterial pressure.
Brain Slice Preparation
After the day following the blood pressure measurement, the rat was anesthetized with isoflurane, and the brain stem was rapidly removed and placed in ice-cold, high-sucrose, artificial cerebrospinal fluid (aCSF) that contained (in mmol/L): 
Electrophysiological Recording
For recording, a single slice was transferred to the recording chamber on an upright epifluorescent microscope (Olympus BX50WI) equipped with infrared differential interference contrast and an optical filter set for visualization of DiA. The slice was held in place with a nylon mesh, submerged in normal aCSF equilibrated with 95% O 2 /5% CO 2 and perfused at a rate of Ϸ2 mL/min. All of the images were captured with a charge-coupled device camera (IR-1000, CCD-100, Dage-MTI) displayed on a television monitor and stored in a personal computer. Patch pipettes were pulled from borosilicate glass capillaries with an inner filament (0.90 mm ID, 1.2 mm OD, WPI) and were filled with a solution of the following composition (in mmol/L): 145 K-gluconate, l MgCl 2 , 10 HEPES, 1.1 EGTA, 2 Mg 2 ATP, and 0.3 Na 3 GTP. The pH was adjusted to 7.3 with KOH. The pipette resistance ranged from 3 to 6 mol/L⍀. A seal resistance of Ն1 G⍀ and an access resistance Ͻ20 mol/L⍀, which changed Ͻ15% during recording, were considered acceptable. Series resistance was optimally compensated. Cells were clamped at a membrane potential of Ϫ60 mV. Input resistances of cells were monitored by applying a 10-mV hyperpolarizing voltage step (100 ms) from a holding potential of Ϫ60 mV. Recordings of postsynaptic currents began 5 minutes later, after whole-cell access was established and the current reached a steady state. Recordings were made with the AxoPatch 200B amplifier and pClamp software version 8 (Axon Instruments). Whole-cell currents were filtered at 2 kHz, digitized at 10 kHz with the DigiData 1200 Interface (Axon Instruments), and stored in a personal computer for offline analysis. All of the experiments were performed at room temperature.
Whole-cell recording experiments were performed in DiA-labeled second-order baroreceptor neurons in medial NTS. All of the experiments were performed in the presence of 1 mol/L of tetrodotoxin (TTX) to block sodium channels and action potentialdependent neurotransmitter release. All of the drugs were dissolved in normal aCSF unless otherwise stated. For recordings of baclofeninduced currents, sequential bath application of baclofen was performed at concentrations of 0.3, 1, 3, 10, 30, and 100 mol/L. Each concentration was applied for 2 min with an interval of Ն15 minutes, during which normal aCSF was applied. To investigate currentvoltage relationships of the baclofen effect, a voltage step protocol was performed in control condition and after holding the current stabilized during application of 10 mol/L of baclofen. Clamping membrane potentials were changed from Ϫ130 mV to Ϫ30 mV in 10-mV steps. The duration of each step was 500 ms, and voltage steps were applied every 2 s.
For recording calcium channel currents, barium was used as the current carrier. The bath solution contained (in mmol/L): 100 NaCl, 40 tetraethylammonium hydrochloride, 2.5 KCl, 5 BaCl 2 , 10 HEPES, and 10 glucose (pH adjusted to 7.3 with NOH). The electrode solution contained (in mmol/L): 140 CsCl, l MgCl 2 , 10 HEPES, 10 EGTA, 2 Mg 2 ATP, and 0.3 Na 3 GTP (the pH was adjusted to 7.3 with CsOH). Barium currents were evoked every 5 s by a 200-ms voltage step from Ϫ60 mV to 40 mV from a holding potential of Ϫ80 mV.
Data Analysis
All of the data were presented as meanϮSEM. For baclofen-induced outward currents, dose-response curves were fitted by the Hill equation:
n H ]}, where I max is the maximum response, EC 50 is the concentration of ligand producing a half-maximal response, and n H is the Hill coefficient. A t test was used to test differences between sham and hypertensive groups. Statistics were performed using SigmaStat (version 2.03, SPSS Software), and graphs were made with SigmaPlot (version 8.0, SPSS Software). Differences were considered statistically significant for PϽ0.05.
Results

Baclofen Effect in Hypertensive Rats
Four weeks after renal wrap or sham surgery, renal wrap hypertensive (HT) rats had significantly higher mean arterial pressure (153Ϯ7 mm Hg; nϭ9) than control normotensive (NT) rats (93Ϯ3 mm Hg; nϭ9; PϽ0.05). All of the in vitro whole-cell recording experiments were performed in medial NTS slices collected the day after blood pressure measurement, and second-order baroreceptor neurons were identified by the presence of DiA-labeled attached boutons ( Figure 1A) . Chronic hypertension did not significantly alter resting membrane characteristics of the second-order NTS neurons. There was no difference in resting membrane potential (54.5Ϯ0.7 mV versus 53.3Ϯ0.6 mV; both nϭ18) and input resistance (1.07Ϯ0.11 G⍀ versus 1.03Ϯ0.11 G⍀; both nϭ18) of second-order neurons between HT and NT rats.
As reported previously, 13 bath application of baclofen induced outward currents in second-order NTS neurons at a holding potential of Ϫ60 mV and in the presence of 1 mol/L TTX, indicating a direct postsynaptic effect ( Figure 1B ). There was a dose-dependent increase in outward current with baclofen application on both NT and HT cells ( Figure 1C) . The EC 50 of baclofen effect was significantly greater in NT rats than in HT rats (9.1Ϯ3.2 mol/L, nϭ5 versus 3.0Ϯ0.5 mol/L, nϭ7; PϽ0.05). During application of 10 mol/L baclofen ( Figure 1D ), HT cells responded with a greater outward current than NT cells (32.6Ϯ4.2 pA, nϭ10 versus 16.3Ϯ2.3 pA, nϭ12; PϽ0.01). This concentration of baclofen elicited a greater reduction in input resistance in HT cells than in NT cells (39Ϯ2% of control, nϭ6 versus 55Ϯ4% of control, nϭ9; PϽ0.05).
Current-voltage relationships were investigated during application of 10 mol/L of baclofen (Figure 2A ). Application of 10 mol/L of baclofen increased the current response to each voltage step. The baclofen equilibrium potential (E b ) was similar between HT and NT cells ( Figure 2B ; 77Ϯ3 mV, nϭ7 versus 74Ϯ2 mV, nϭ6; PϾ0.05). There was a significant increase in slope conductance in all of the second-order neurons during the 10 mol/L of baclofen application, as calculated from the slope of current-voltage curve between Ϫ130 mV and 40 mV. However, HT cells had greater increase in conductance than NT cells (254Ϯ31%, nϭ6 versus 184Ϯ13%, nϭ7; PϽ0.05).
GABA B Receptors Mediate Baclofen Effect
In 2 NT cells, application of 20 mol/L of selective GABA B receptor antagonist SCH 50911 did not induce discernible change on holding currents, indicating no tonic activation of postsynaptic GABA B receptors in the brain slice from NT rats. To confirm the selective effect of baclofen on GABA B receptors, coapplication of 10 mol/L of baclofen with 20 mol/L of SCH 50911 did not significantly alter holding current currents, suggesting that baclofen-evoked outward current was because of activation of GABA B receptors. After washout, baclofen application induced outward currents of 13.9Ϯ1.4 pA.
Ionic Mechanisms of Baclofen Effect
Under our experimental conditions, the calculated potassium equilibrium potential was Ϫ98 mV, which was more negative than E b presented above (74Ϯ2 mV; nϭ6). Thus, a separate group of 16 control NT rats was used to identify the ionic mechanisms of the baclofen-induced current. Application of 1 mmol/L of barium, a nonselective potassium channel blocker, induced a mild, apparently inward current of 6.9Ϯ2.1 pA (nϭ6) coupled with an increase in membrane resistance (136Ϯ9% of control; PϽ0.05). Coapplication of 10 mol/L of baclofen with barium significantly reduced the evoked outward current in NTS neurons (8.0Ϯ1.2 pA versus 16.3Ϯ2.3 pA; PϽ0.05) and attenuated the baclofen-evoked reduction in input resistance (65Ϯ3% of control versus 55Ϯ4% of control; PϽ0.05). Furthermore, after application of 1 mmol/L barium, the E b shifted to more positive potentials (Ϫ63Ϯ8 mV; nϭ5; Figure 3A) than the E b under control condition (74Ϯ2 mV; nϭ6). These data suggest that the baclofen effect on second-order baroreceptor neurons in the NTS was largely mediated by potassium channels.
Baclofen has been reported to alter calcium currents. 19 -21 Therefore, we investigated the role of calcium channels in a baclofen-induced current. In the presence of 200 mol/L of cadmium, a nonselective calcium channel blocker, the reversal potential of the baclofen-induced current shifted to the more negative value of Ϫ100Ϯ15 mV (nϭ5), that is, close to the calculated potassium equilibrium potential of Ϫ98 mV under our experimental conditions ( Figure 3B ). We also investigated baclofen-mediated inhibition of calcium channels by measuring the baclofen effect on barium currents in 7 NTS cells. Baclofen (10 mol/L) was applied after stable barium currents were obtained. The voltage-activated barium currents were detectable at Ϫ40 mV and peaked at Ϫ10 mV. The inverted bell shape of the current-voltage curve was not changed by baclofen. We observed an inhibition of barium currents during baclofen application. The inhibition by 10 mol/L of baclofen was 18.9Ϯ5.8% at 0 mV and 21.4Ϯ5.1% at Ϫ10 mV (all PϽ0.05; Figure 3C ). Cadmium (200 mol/L) abolished barium currents, confirming that the currents were carried through calcium channels.
Discussion
These results demonstrate that activation of postsynaptic GABA B receptors with baclofen induces outward currents in second-order baroreceptor neurons in the NTS, which will decrease neuronal excitability. This GABA B receptor-mediated inhibitory effect was enhanced after chronic hypertension. Both potassium and calcium channels were involved in the baclofen-evoked currents in the NTS. Enhanced postsynaptic GABA B receptor function could contribute to the enhanced baclofen-induced pressor response observed in vivo in various animal models of chronic hypertension. Our present study did not examine presynaptic inhibition by baclofen. This component of baclofen-mediated inhibition may or may not be altered in chronic hypertension.
An initial key component of the baroreflex arc is the synaptic integration of baroreceptor afferent inputs within the NTS. Baclofen decreases the action potential discharge of NTS neurons receiving baroreceptor afferent inputs 6, 8 and induces a pressor response. 3 Activation of GABA B receptors can presynaptically inhibit excitatory neurotransmitter release and decrease postsynaptic neuronal excitability via activation of a potassium conductance, 13 thus reducing the transmission of baroreceptor afferent inputs to other sites in baroreflex pathways. 2 An enhanced baclofen-induced pressor response is a well-described phenomenon after chronic hypertension, suggesting an enhanced inhibitory effect of baclofen. However, it is difficult to achieve conclusive evidence on the role of presynaptic and/or postsynaptic mechanisms underlying the baclofen-induced pressor response and its alterations in hypertension using an in vivo approach. The current study used in vitro whole-cell recording methods to directly investigate the postsynaptic responses to baclofen after chronic hypertension. We observed that chronic hypertension significantly enhanced baclofen-induced postsynaptic outward currents. There is significantly lower EC 50 for baclofen-induced outward current comparing HT with NT cells, suggesting that chronic hypertension enhanced neuronal sensitivity to baclofen. The results of the current study are consistent with previous biochemical studies on NTS GABA B receptors. A previous study from our laboratory has found that in the NTS of renal-wrap HT rats there is increased expression of GABA B Figure 3 . Ionic mechanisms of baclofen-induced current. A, effect of barium on current-voltage relationship in second-order baroreceptor neurons in the NTS (nϭ5). Barium itself induced an apparent inward current by blocking potassium channels. In the presence of barium, the baclofen equilibrium potential shifted to more positive level (Ϫ63Ϯ8 mV). B, when 10 mol/L of baclofen was coapplied with 200 mol/L of cadmium (nϭ5), the baclofen equilibrium potential was shifted to a more negative level comparing with baclofen alone in Figure 2 . C, current-voltage relationship of normalized barium currents before and during the application of 10 mol/L of baclofen (nϭ7). Inset, an example of voltage-activated barium current inhibited by 10 mol/L of baclofen. All of the experiments were performed in the presence of 1 mol/L of TTX. receptor mRNA. 7 A similar study reported that baclofen binding in the NTS was increased in spontaneously hypertensive rats when compared with control rats. 22 The enhanced baclofen effect could be mediated by an increased number of GABA B receptors and/or increased flow through individual channels on second-order neurons after chronic hypertension.
The changes that we report here are considered adaptations in response to a chronically elevated blood pressure. The exact stimulus, or stimuli, that induces an increase of postsynaptic response to activation of GABA B receptors is unknown. The stimulus could be increased excitatory baroreceptor afferent inputs to NTS neurons because of the elevated blood pressure. The stimulus could be systemic and/or local tissue-generated neurohormonal alterations in chronic hypertension (eg, angiotensin).
In the present study, the baclofen equilibrium potential was more positive than the potassium reversal potential. Our result is similar to the baclofen equilibrium potential of Ϫ73 mV reported in a previous study in medial NTS under a similar experimental condition. 13 Postsynaptic baclofen effects are primarily mediated by activation of potassium channels. 19, 21 In addition, baclofen also inhibits voltagedependent calcium channels. 19 -21 Our results confirmed these findings and showed that blocking voltage-dependent calcium channels shifted E b closer to potassium equilibrium potential, whereas blocking potassium channels shifted E b further away from potassium equilibrium potential, suggesting that both channels are involved in the baclofen effect on second-order baroreceptor neurons in the NTS. Future studies will be needed to explore the role of different types of calcium and potassium channels and their relative contributions to the enhanced baclofen-induced inhibition observed in chronic hypertension.
Perspectives
The baroreflex serves to minimize arterial blood pressure fluctuation under physiological conditions and remains functional in chronic hypertension. However, baroreflex regulation of sympathetic discharge is reset to higher pressures in chronic hypertension. 14 It has been proposed that this resetting reflects a new balance between increased excitatory afferent inputs because of increased blood pressure and GABA-mediated inhibition. 2 Such balance would maintain regulatory function of baroreflex during chronic hypertension. Enhanced GABA B receptor-mediated inhibition could be a crucial factor in baroreflex adaptation in chronic hypertension. 2, 10 The current study provides direct evidence of an enhanced postsynaptic baclofen effect on second-order baroreceptor neurons in the NTS. This enhanced postsynaptic GABA B receptor function could be crucial in modulating baroreflex function in chronic hypertension. Future studies will investigate the effect of chronic hypertension on presynaptic GABA B receptor function, including both excitatory and inhibitory inputs to second-order NTS neurons. Furthermore, the impact of chronic hypertension on different ion channels mediating postsynaptic baclofen effects will be investigated.
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